Clever Culture System (Diagnostic Equipment) Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Stock Symbol
  • CC5

Stock Symbol

  • Investments
  • 2

Clever Culture System (Diagnostic Equipment) General Information

Description

Clever Culture Systems Ltd is engaged in developing and commercialising the APAS Independence. The group operates in one business segment, being the development and commercialisation of innovative technologies. It has presence in USA, UK, Germany, Denmark, Australia, Netherlands, Sweden, China, and France. The company generates majority of revenue from USA. Its industries are Pharma, and Clinical.

Contact Information

Formerly Known As
Labtech Systems, LBT Innovations
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 16 Anster Street
  • Adelaide, South Australia 5000
  • Australia
+61 (08)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Stock Exchange
ASX
Corporate Office
  • 16 Anster Street
  • Adelaide, South Australia 5000
  • Australia
+61 (08)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clever Culture System (Diagnostic Equipment) Stock Performance

As of 12-Nov-2026, Clever Culture System (Diagnostic Equipment)’s current market cap is $21.5M with 2.24B shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $21.5M 2.24B 883K

Clever Culture System (Diagnostic Equipment) Financials Summary

As of 30-Sep-2026, Clever Culture System (Diagnostic Equipment) has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 28,350 33,268 18,314 14,376
Revenue 3,129 3,533 823
EBITDA (2,631) 106 (2,689)
Net Income (1,516) 1,090 (2,451)
Total Assets 9,323 7,034 5,301
Total Debt 2,053 1,447 2,134
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Clever Culture System (Diagnostic Equipment) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Clever Culture System (Diagnostic Equipment)‘s full profile, request access.

Request a free trial

Clever Culture System (Diagnostic Equipment) Patents

Clever Culture System (Diagnostic Equipment) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-201611929-S A test chart Inactive 08-Apr-2016
AU-201611930-S A test chart Inactive 08-Apr-2016
AU-2016901315-A0 Method and system for validating resolvable detail across a depth of field Inactive 08-Apr-2016
WO-2017173501-A1 Method and system for validating resolvable detail across a depth of field Inactive 08-Apr-2016
WO-2017173500-A1 Method and test chart for testing operation of an image capture system Inactive 08-Apr-2016 H04N17/002
To view Clever Culture System (Diagnostic Equipment)’s complete patent history, request access »

Clever Culture System (Diagnostic Equipment) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Clever Culture System (Diagnostic Equipment)‘s full profile, request access.

Request a free trial

Clever Culture System (Diagnostic Equipment) Investments & Acquisitions (2)

Clever Culture System (Diagnostic Equipment)’s most recent deal was a Merger/Acquisition with Clever Culture Systems (Acquired/Merged) for . The deal was made on 31-Dec-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Clever Culture Systems (Acquired/Merged) 31-Dec-2021 Merger/Acquisition Other Devices and Supplies
Clever Culture Systems (Acquired/Merged) 01-Jan-2013 Joint Venture Other Devices and Supplies
To view Clever Culture System (Diagnostic Equipment)’s complete investments and acquisitions history, request access »

Clever Culture System (Diagnostic Equipment) ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Clever Culture System (Diagnostic Equipment)’s complete esg history, request access »

Clever Culture System (Diagnostic Equipment) FAQs

  • When was Clever Culture System (Diagnostic Equipment) founded?

    Clever Culture System (Diagnostic Equipment) was founded in 2004.

  • Where is Clever Culture System (Diagnostic Equipment) headquartered?

    Clever Culture System (Diagnostic Equipment) is headquartered in Adelaide, Australia.

  • What industry is Clever Culture System (Diagnostic Equipment) in?

    Clever Culture System (Diagnostic Equipment)’s primary industry is Diagnostic Equipment.

  • Is Clever Culture System (Diagnostic Equipment) a private or public company?

    Clever Culture System (Diagnostic Equipment) is a Public company.

  • What is Clever Culture System (Diagnostic Equipment)’s stock symbol?

    The ticker symbol for Clever Culture System (Diagnostic Equipment) is CC5.

  • What is the current market cap of Clever Culture System (Diagnostic Equipment)?

    The current market capitalization of Clever Culture System (Diagnostic Equipment) is $21.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process